TERT-BUTYL 4-(2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 100mg

2-Chloro-4-nitrobenzamide, 98.0%, 25g

Theobromine>98.0%(HPLC)(T)500g

L(-)-fucosa, mínimo 99 %, para bioquímica, 25 g, envase de vidrio

Pieza de transición, 45/40, 29/32, 1 Pieza

1-(Pyrazin-2-yl)cyclopropanecarboxylic acid, 95.0%, 100mg

Methyl 6-amino-5-hydroxynicotinate, 95.0%, 1g

(S)-1-Pyrrolidin-2-benzyl-2-(N-Cbz-N-methyl)amino-ethane, 97.0%, 1g

1,3-Di(4H-1,2,4-triazol-4-yl)benzene, 98%, 250mg

5-Iodo-3-methyl-1-benzofuran-2-carboxylic acid, 95%, 250mg

(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity), 97%, 50mg

3,5-Dimethoxybenzoic acid, 95.0%, 1kg

2,3,5-Trifluoro-4-trifluoromethyl-phenylamine, 100mg